EpiSweep: Computationally Driven Reengineering of Therapeutic Proteins to Reduce Immunogenicity While Maintaining...

Area of Science:

• Biotechnology
• Computational Biology
• Drug Development

Background:

• Therapeutic proteins can trigger immune responses, leading to reduced efficacy and adverse reactions.
• Deimmunization is crucial for clinical application but must maintain protein function.

Purpose of the Study:

• To develop and validate a computational approach for protein deimmunization.
• To create algorithms that balance reduced immunogenicity with preserved therapeutic activity.

Main Methods:

• Developed the EpiSweep suite of protein design algorithms.
• Integrated T cell epitope prediction with mutation impact assessment on protein stability and function.
• Applied Pareto optimal trade-offs for deimmunization strategies.

Main Results:

• EpiSweep effectively identifies mutations to reduce immunogenicity while maintaining protein function.
• Validated through retrospective case studies and prospective experimental applications.
• Demonstrated high effectiveness in deimmunizing various therapeutic candidates.

Conclusions:

• EpiSweep provides a broadly applicable computational tool for protein deimmunization.
• Accelerates the development of novel protein therapeutics by improving efficiency and success rates.